Relationship between serum uric acid level and metabolic syndrome according to gender

Korean Circulation Journal

Volumn 38, Issue 3, 2008, Pages 152-160

  Hong, Seung Pyo ^a   Lee, Young Soo ^a   Bae, Kyung Ryun ^a   Chung, Jin Wook ^a   Kim, So Yeon ^a   Lee, Jin Bae ^a   Ryu, Jae Kean ^a   Choi, Ji Yong ^a   Kim, Kee Sik ^a   Chang, Sung Gug ^a   Shin, Im Hee ^a  

^a Catholic University of Daegu   (South Korea)

Author keywords

Gender; Metabolic syndrome; Uric acid

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; HYPERURICEMIA; MALE; MASS SCREENING; METABOLIC SYNDROME X; URIC ACID BLOOD LEVEL;

EID: 78649916143     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2008.38.3.152     Document Type: Article

References (18)

1. Costa A, Iguala I, Bedini J, Quinto L, Conget I. Uric acid concentration in subjects at risk of type 2 diabetes mellitus: relationship to components of the metabolic syndrome. Metabolism 2002;51:372-5.
2. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003;52:1210-4.
3. Cha BS, Kim HJ. Metabolic syndrome and cardiovascular disease. Korean Circ J 2003;33:645-52.
4. Regitz-Zagrosek V, Lehmkuhl E, Weickert MO. Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clin Res Cardiol 2006;95:136-47.
5. Curb JD, Ford C, Hawkins CM, et al. A coordinating center in a clinical trial: the hypertension detection and followup program. Control Clin Trials 1983;4:171-86.
6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP ) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III ). JAMA 2001;285:2486-97.
7. Einhorn D, Reaven GM, Cobin RH, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 2003;9:237-52.
8. Park HS, Oh SW, Kang JH, et al. Prevalence and associated factors with metabolic syndrome in South Korea: from the Korean National Health and Nutrition Examination Survey, 1998. J Korean Soc Study Obes 2003;12:1-14.
9. International Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment. Western Pacific Region; 2000.
10. Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant-and radical- caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A 1981;78:6858-62.
11. Yoo TW, Sung KC, Kim YC, et al. The relationship of the Hypertension, insulin resistance, and metabolic syndrome in the serum uric acid level. Korean Circ J 2004;34:874-82.
12. Sumino H, Ichikawa S, Kanda T, Nakamura T, Sakamaki T. Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia. Lancet 1999;354:650.
13. Waring WS, Adwani SH, Breukels O, Webb DJ, Maxwell SR. Hyperuricaemia does not impair cardiovascular function in healthy adults. Heart 2004;90:155-9.
14. Alderman MH, Cohen H, Madhavan S, Kinlighn S. Serum uric acid and cardiovascular events in successfuolly treated hypertensive patients. Hypertension 1999;34:144-50.
15. Sowers JR, Lester MA. Diabetes and cardiovascular disease. Dabetes Care 1999;22 (Suppl 3 ):C14-20.
16. Kim JH, Moon HS. Health perception, body image, sexual function and depression in menopausal women according to menopausal stages. J Korean Acad Nurs 2006;36:449-56.
17. Jitapunkul S, Chalapraprawat M, Bunnag S, et al. The relationship between glucose and uric acid metabolism: influence of short term allopurinol on glucose metabolism. J Med Assoc Thai 1991;74:80-6.
18. Yun JW, Kang JM, Lee WY, Kim SW. Plasma uric acid concentrations represent the degree of metabolic control and diabetic complications in type 2 diabetes. Korean J Med 2003;64:78-84.